Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study).

Gergő A MolnárZoltán VokóGábor SütőGyörgy RokszinDávid NagyGyörgy SurjánOrsolya SurjánPéter NagyIstván KenesseyAndrás WéberMihály PálosiCecília MüllerMiklós KáslerIstván WittmannZoltan Kiss

Published in: BMJ open diabetes research & care (2024)

Our data suggest that people with type 2 diabetes may have even higher health gain when getting vaccinated as compared with non-diabetic persons, eliminating the marked, COVID-19-related excess risk of this population. Boosters could restore protection.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
healthcare
public health
randomized controlled trial
type diabetes
systematic review
mental health
health information
risk assessment
drug induced
artificial intelligence
deep learning